Network TV show in the works for Everyday Health

Share this article:
Everyday Health is planting its flag in network television with an ABC show that is being produced by “The Biggest Loser” creator Mark Koops.

The half-hour show, “Everyday Health,” will air as part of a three-hour block of programming following Good Morning America Saturday mornings on 95% of the nation's ABC affiliate stations, beginning in September. The concept for the show is “Extreme Makeover: Home Edition” meets “The Doctors,” a spokesperson said, and will feature patients who have sought to help others with similar conditions – for example, Jesse Billauer, a surfer rendered quadriplegic by a spinal injury who went on to start Life Rolls On, a division of the Christopher & Dana Reeve Foundation which helps surfers who have suffered spinal injuries.

The programming block, dubbed “Weekend Adventure,” includes “Jack Hanna's Wild Countdown” and “Ocean Mysteries,” and is produced by Litton Entertainment, which will manage ad sales and distribution for the show. Everyday Health co-founders Ben Wolin, CEO, and Mike Keriakos, president, are co-producing the show along with Koops.

“This show will celebrate health-related philanthropy, demonstrating how one person can make a world of difference in someone else's life,” said Keriakos.

Everyday Health will plug the show through its digital channels, which boast 28 million unique users per month, and will create a dedicated site for the show on EverydayHealth.com.
Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.